#Only high confidence data is provided, i.e., samples with >0.90 reconstruction accuracy and at least 10 mutations attributed to the specific SBS signature.
Study	Cancer.Types	Scale	Sample.Names	Sample.Accuracy	SBS11.Mutations
PCAWG-WGS	CNS-GBM	genome	SP25494	0.988	213551
PCAWG-WGS	Panc-Endocrine	genome	SP135460	0.962	172
PCAWG-WGS	Panc-Endocrine	genome	SP102567	0.973	490
nonPCAWG-WES	CNS-GBM	exome	R010_Prim	0.942	74
nonPCAWG-WES	CNS-LGG	exome	Glio_20764/21423	0.987	2183
nonPCAWG-WES	CNS-LGG	exome	Glio_23700/24800	0.927	228
nonPCAWG-WES	Skin-Melanoma	exome	PD10021a	0.996	880
nonPCAWG-WES	Skin-Melanoma	exome	PD9032a	0.965	15
nonPCAWG-WES	Skin-Melanoma	exome	SKCM-JWCI-WGS-23-Tumor	0.994	10
nonPCAWG-WES	Skin-Melanoma	exome	SKCM-JWCI-WGS-38-Tumor	0.989	28
nonPCAWG-WES	Skin-Melanoma	exome	SKCM-Ma-Mel-16-Tumor	0.983	11
nonPCAWG-WES	Skin-Melanoma	exome	96T	0.975	12
nonPCAWG-WES	Skin-Melanoma	exome	YUPEET	0.975	20
nonPCAWG-WES	Skin-Melanoma	exome	YUSCO	0.956	31
nonPCAWG-WES	Skin-Melanoma	exome	LAU618	0.981	20
nonPCAWG-WES	Skin-Melanoma	exome	ME011T	0.979	170
nonPCAWG-WES	Skin-Melanoma	exome	ME029T	0.988	107
nonPCAWG-WES	Skin-Melanoma	exome	ME030T	0.98	29
nonPCAWG-WES	Skin-Melanoma	exome	ME045T	0.983	27